Page last updated: 2024-10-25

deferoxamine and Tongue Neoplasms

deferoxamine has been researched along with Tongue Neoplasms in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Tongue Neoplasms: Tumors or cancer of the TONGUE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, X1
Huang, D1
Xue, Z1
Xu, X1
Wang, K1
Sun, Y1
Kang, F1

Other Studies

1 other study available for deferoxamine and Tongue Neoplasms

ArticleYear
Effect of HIF-1α on biological activation of human tongue squamous cell carcinoma SCC-15 cells in vitro.
    International journal of oncology, 2015, Volume: 46, Issue:6

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deferoxami

2015